Zynerba Pharmaceuticals CEO Armando Anido's 2018 pay slips 18% to $2M
Zynerba Pharmaceuticals reports 2018 executive compensation
By ExecPay News
Published: April 25, 2019
Zynerba Pharmaceuticals reported fiscal year 2018 executive compensation information on April 25, 2019.
In 2018, three executives at Zynerba Pharmaceuticals received on average a compensation package of $1.5M, a 12% decrease compared to previous year.
Average pay of disclosed executives at Zynerba Pharmaceuticals
Armando Anido, Chief Executive Officer, received $2M in total, which decreased by 18% compared to 2017. 54% of Anido's compensation, or $1.1M, was in option awards. Anido also received $290K in non-equity incentive plan, $568K in salary, as well as $54K in other compensation.
Terri B. Sebree, President, received a compensation package of $1.3M, which decreased by 20% compared to previous year. 46% of the compensation package, or $591K, was in option awards.
James E. Fickenscher, Chief Financial Officer, earned $1.1M in 2018, a 19% increase compared to previous year.
Related executives
You may also like
Source: SEC filing on April 25, 2019.